Repare Therapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 150

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $78.7M

Repare Therapeutics General Information

Description

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 7171 Frederick-Banting
  • Building 2
  • Saint-Laurent, Quebec H4S 1Z9
  • Canada
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • 7171 Frederick-Banting
  • Building 2
  • Saint-Laurent, Quebec H4S 1Z9
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Repare Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 28-Jan-2026 $78.7M Completed Generating Revenue
6. 2PO 01-Nov-2021 Completed Generating Revenue
5. IPO 19-Jun-2020 Completed Pre-Clinical Trials
4. Early Stage VC 29-May-2020 Completed Pre-Clinical Trials
3. Early Stage VC (Series B) 04-Sep-2019 Completed Startup
2. Early Stage VC (Series A) 22-Jun-2017 $68M $68M Completed Startup
1. Accelerator/Incubator Completed Startup
To view Repare Therapeutics’s complete valuation and funding history, request access »

Repare Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Repare Therapeutics’s complete cap table history, request access »

Repare Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based
Drug Discovery
Saint-Laurent, Canada
150 As of 2025

San Diego, CA
 

Wilmington, DE
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Repare Therapeutics Competitors (85)

One of Repare Therapeutics’s 85 competitors is ImmunityBio, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ImmunityBio Formerly VC-backed San Diego, CA
Ayala Pharmaceuticals Corporation Wilmington, DE
Sorrento Therapeutics Formerly VC-backed San Diego, CA
Intellia Therapeutics Formerly VC-backed Cambridge, MA
Sangamo Therapeutics Formerly VC-backed Richmond, CA
You’re viewing 5 of 85 competitors. Get the full list »

Repare Therapeutics Patents

Repare Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026125935-A1 Methods of treating cancers having fbxw7 mutations Pending 09-Dec-2024
WO-2026003756-A1 Methods of determining pharmacodynamic activity and treatment efficacy Pending 25-Jun-2024
WO-2025255237-A1 Use of atr inhibitors in combination with radioligand therapy for the treatment of cancer Pending 04-Jun-2024
WO-2025177244-A1 Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use Pending 22-Feb-2024
WO-2025169150-A1 Crystalline forms, crystalline salt forms, compositions containing the same, and methods of using the same Pending 09-Feb-2024 A61P35/00
To view Repare Therapeutics’s complete patent history, request access »

Repare Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Repare Therapeutics Former Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Amplitude Ventures Venture Capital Minority
BDC Capital Growth/Expansion Minority
BVF Partners Hedge Fund Minority
Bristol-Myers Squibb Corporation Minority
Celgene Corporation Minority
You’re viewing 5 of 15 investors. Get the full list »

Repare Therapeutics Investments (1)

Repare Therapeutics’s most recent deal was a Early Stage VC with DCx Biotherapeutics. The deal was made on 01-Jan-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
DCx Biotherapeutics 01-Jan-2025 Early Stage VC Biotechnology
To view Repare Therapeutics’s complete investments history, request access »

Repare Therapeutics ESG

Risk Overview

Risk Rating

Updated December, 31, 2022

31.93 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 16,216

Rank

Percentile

Pharmaceuticals

Industry

of 921

Rank

Percentile

Pharmaceuticals

Subindustry

of 452

Rank

Percentile

To view Repare Therapeutics’s complete esg history, request access »

Repare Therapeutics FAQs

  • When was Repare Therapeutics founded?

    Repare Therapeutics was founded in 2016.

  • Where is Repare Therapeutics headquartered?

    Repare Therapeutics is headquartered in Saint-Laurent, Canada.

  • What is the size of Repare Therapeutics?

    Repare Therapeutics has 150 total employees.

  • What industry is Repare Therapeutics in?

    Repare Therapeutics’s primary industry is Drug Discovery.

  • Is Repare Therapeutics a private or public company?

    Repare Therapeutics is a Private company.

  • What is the current valuation of Repare Therapeutics?

    The current valuation of Repare Therapeutics is .

  • What is Repare Therapeutics’s current revenue?

    The current revenue for Repare Therapeutics is .

  • How much funding has Repare Therapeutics raised over time?

    Repare Therapeutics has raised $520M.

  • Who are Repare Therapeutics’s investors?

    Amplitude Ventures, BDC Capital, BVF Partners, Bristol-Myers Squibb, and Celgene are 5 of 15 investors who have invested in Repare Therapeutics.

  • Who are Repare Therapeutics’s competitors?

    ImmunityBio, Ayala Pharmaceuticals, Sorrento Therapeutics, Intellia Therapeutics, and Sangamo Therapeutics are some of the 85 competitors of Repare Therapeutics.

  • When was Repare Therapeutics acquired?

    Repare Therapeutics was acquired on 28-Jan-2026.

  • Who acquired Repare Therapeutics?

    Repare Therapeutics was acquired by XenoTherapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process